Working… Menu

Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept. (RESCUE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01972763
Recruitment Status : Completed
First Posted : October 30, 2013
Last Update Posted : February 5, 2019
Genentech, Inc.
Information provided by (Responsible Party):
Northern California Retina Vitreous Associates

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2018
Actual Study Completion Date : July 2018